Literature DB >> 34343135

Basal epithelial stem cells cross an alarmin checkpoint for postviral lung disease.

Kangyun Wu1, Kenji Kamimoto2,3, Yong Zhang1, Kuangying Yang1,4, Shamus P Keeler1, Benjamin J Gerovac1, Eugene V Agapov1, Stephen P Austin1, Jennifer Yantis1, Kelly A Gissy1, Derek E Byers1, Jennifer Alexander-Brett1,5, Christy M Hoffmann1, Matthew Wallace1, Michael E Hughes1,2, Erika C Crouch5, Samantha A Morris2,3, Michael J Holtzman1,6.   

Abstract

Epithelial cells are charged with protection at barrier sites, but whether this normally beneficial response might sometimes become dysfunctional still needs definition. Here, we recognized a pattern of imbalance marked by basal epithelial cell growth and differentiation that replaced normal airspaces in a mouse model of progressive postviral lung disease due to the Sendai virus. Single-cell and lineage-tracing technologies identified a distinct subset of basal epithelial stem cells (basal ESCs) that extended into gas-exchange tissue to form long-term bronchiolar-alveolar remodeling regions. Moreover, this cell subset was selectively expanded by crossing a cell-growth and survival checkpoint linked to the nuclear-localized alarmin IL-33 that was independent of IL-33 receptor signaling and instead connected to autocrine chromatin accessibility. This mechanism creates an activated stem-progenitor cell lineage with potential for physiological or pathological function. Thus, conditional loss of Il33 gene function in basal epithelial cells disrupted the homeostasis of the epithelial barrier at skin and gut sites but also markedly attenuated postviral disease in the lung based on the downregulation of remodeling and inflammation. Thus, we define a basal ESC strategy to deploy innate immune machinery that appears to overshoot the primordial goal of self-defense. Our findings reveal new targets to stratify and correct chronic and often deadly postviral disease.

Entities:  

Keywords:  Asthma; Innate immunity; Macrophages; Pulmonology

Mesh:

Substances:

Year:  2021        PMID: 34343135      PMCID: PMC8483760          DOI: 10.1172/JCI149336

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  64 in total

1.  17β-Estradiol protects the esophageal epithelium from IL-13-induced barrier dysfunction and remodeling.

Authors:  Justin C Wheeler; Simone Vanoni; Chang Zeng; Lisa Waggoner; Yanfen Yang; David Wu; Jazib Uddin; Rebekah Karns; Leah Kottyan; Vincent Mukkada; Marc E Rothenberg; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2018-12-20       Impact factor: 10.793

2.  Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung.

Authors:  Jonathan L McQualter; Karen Yuen; Brenda Williams; Ivan Bertoncello
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

3.  Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells.

Authors:  Lidia Bosurgi; Y Grace Cao; Mar Cabeza-Cabrerizo; Andrea Tucci; Lindsey D Hughes; Yong Kong; Jason S Weinstein; Paula Licona-Limon; Edward T Schmid; Facundo Pelorosso; Nicola Gagliani; Joseph E Craft; Richard A Flavell; Sourav Ghosh; Carla V Rothlin
Journal:  Science       Date:  2017-05-11       Impact factor: 47.728

4.  Progenitor identification and SARS-CoV-2 infection in human distal lung organoids.

Authors:  Ameen A Salahudeen; Shannon S Choi; Arjun Rustagi; Junjie Zhu; Vincent van Unen; Sean M de la O; Ryan A Flynn; Mar Margalef-Català; António J M Santos; Jihang Ju; Arpit Batish; Tatsuya Usui; Grace X Y Zheng; Caitlin E Edwards; Lisa E Wagar; Vincent Luca; Benedict Anchang; Monica Nagendran; Khanh Nguyen; Daniel J Hart; Jessica M Terry; Phillip Belgrader; Solongo B Ziraldo; Tarjei S Mikkelsen; Pehr B Harbury; Jeffrey S Glenn; K Christopher Garcia; Mark M Davis; Ralph S Baric; Chiara Sabatti; Manuel R Amieva; Catherine A Blish; Tushar J Desai; Calvin J Kuo
Journal:  Nature       Date:  2020-11-25       Impact factor: 49.962

Review 5.  Stem Cells in Repair of Gastrointestinal Epithelia.

Authors:  Amanda Andersson-Rolf; Matthias Zilbauer; Bon-Kyoung Koo; Hans Clevers
Journal:  Physiology (Bethesda)       Date:  2017-07

6.  IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow.

Authors:  Matthew T Stier; Jian Zhang; Kasia Goleniewska; Jacqueline Y Cephus; Mark Rusznak; Lan Wu; Luc Van Kaer; Baohua Zhou; Dawn C Newcomb; R Stokes Peebles
Journal:  J Exp Med       Date:  2017-12-08       Impact factor: 14.307

7.  p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration.

Authors:  Wei Zuo; Ting Zhang; Daniel Zheng'An Wu; Shou Ping Guan; Audrey-Ann Liew; Yusuke Yamamoto; Xia Wang; Siew Joo Lim; Matthew Vincent; Mark Lessard; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Nature       Date:  2014-11-12       Impact factor: 49.962

8.  Persistent Symptoms in Patients After Acute COVID-19.

Authors:  Angelo Carfì; Roberto Bernabei; Francesco Landi
Journal:  JAMA       Date:  2020-08-11       Impact factor: 56.272

9.  IL-13-induced airway mucus production is attenuated by MAPK13 inhibition.

Authors:  Yael G Alevy; Anand C Patel; Arthur G Romero; Dhara A Patel; Jennifer Tucker; William T Roswit; Chantel A Miller; Richard F Heier; Derek E Byers; Tom J Brett; Michael J Holtzman
Journal:  J Clin Invest       Date:  2012-11-26       Impact factor: 14.808

10.  Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor.

Authors:  William J Zacharias; David B Frank; Jarod A Zepp; Michael P Morley; Farrah A Alkhaleel; Jun Kong; Su Zhou; Edward Cantu; Edward E Morrisey
Journal:  Nature       Date:  2018-02-28       Impact factor: 49.962

View more
  9 in total

1.  Alveolar Repair after Viral Injury: A Tale of Two Cell Types.

Authors:  Sara Kass-Gergi; Andrew E Vaughan
Journal:  Am J Respir Cell Mol Biol       Date:  2022-09       Impact factor: 7.748

2.  Intermediary Role of Lung Alveolar Type 1 Cells in Epithelial Repair upon Sendai Virus Infection.

Authors:  Belinda J Hernandez; Margo P Cain; Anne M Lynch; Jose R Flores; Michael J Tuvim; Burton F Dickey; Jichao Chen
Journal:  Am J Respir Cell Mol Biol       Date:  2022-09       Impact factor: 7.748

3.  Nuclear IL-33 as a growth and survival agent within basal cells.

Authors:  Harold A Chapman
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 19.456

4.  Interleukin (IL)-33 immunobiology in asthma and airway inflammatory diseases.

Authors:  Rohit Gaurav; Jill A Poole
Journal:  J Asthma       Date:  2021-12-27

5.  Chloride channel accessory 1 gene deficiency causes selective loss of mucus production in a new pig model.

Authors:  Shamus P Keeler; Jennifer Yantis; Benjamin J Gerovac; Samuel L Youkilis; Stephanie Podgorny; Dailing Mao; Yong Zhang; Kristin M Whitworth; Bethany Redel; Melissa S Samuel; Kevin D Wells; Randall S Prather; Michael J Holtzman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-04-19       Impact factor: 6.011

6.  Is IL-1β a Target for Reducing Hospitalization of Infants Infected with Respiratory Syncytial Virus?

Authors:  Yohannes A Mebratu; Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2022-03       Impact factor: 6.914

7.  Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron.

Authors:  Zhenlu Chong; Courtney E Karl; Peter J Halfmann; Yoshihiro Kawaoka; Emma S Winkler; Shamus P Keeler; Michael J Holtzman; Jinsheng Yu; Michael S Diamond
Journal:  Cell Rep       Date:  2022-04-21       Impact factor: 9.995

8.  Lung remodeling regions in long-term Covid-19 feature basal epithelial cell reprogramming.

Authors:  Kangyun Wu; Yong Zhang; Stephen R Austin; Huqing Yin Declue; Derek E Byers; Erika C Crouch; Michael J Holtzman
Journal:  medRxiv       Date:  2022-09-19

9.  An alternative mechanism for skeletal muscle dysfunction in long-term post-viral lung disease.

Authors:  Ryan A Martin; Shamus P Keeler; Kangyun Wu; William J Shearon; Devin Patel; My Hoang; Christy M Hoffmann; Michael E Hughes; Michael J Holtzman
Journal:  bioRxiv       Date:  2022-10-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.